August 22, 2013 – Study published by Vanderbilt University finds a 3-fold increased risk of type 2 diabetes in children who take Abilify for non-psychosis-related disorders.
August 22, 2013 – Study published by Vanderbilt University finds a 3-fold increased risk of type 2 diabetes in children who take Abilify for non-psychosis-related disorders.